8. targeted therapy in cancer Flashcards
1
Q
what do targeted therapy in cancer do?
A
Exploits biological weaknesses in tumours
- Faulty genes
- Faulty signalling systems
- Tumour growth
- Angiogenesis
2
Q
Tamoxifen
A
Hormone based therapy
- Blocks oestrogen as a selective estrogen-receptor modulator (SERM)
- Prevents breast cancer- stops spread
- Reduces growth of oestrogen-driven breast cancer
- Used in estrogen receptor positive (ER+) breast cancer
- As a receptor modulator: prevents bone loss via oestrogenic effects
- Early menopause as blocking effect of oestrogen
3
Q
which hormone promotes growth in metastatic cells
A
oestrogen
4
Q
Aromatase inhibitors
A
- Prevents peripheral conversion of androgen to oestrogen
- second approach following tamoxifen
5
Q
HER2 receptor
A
- Naturally present in low levels
- But over expressed in some cancers eg breast cancer
- More likely in older patients
- Due to oncogene (ERBB2)
- Affects gene transcription and cell cycle
*
6
Q
Trastuzumab
A
- Monoclonal antibody- specific
- Targets human epidermal growth factor receptor-2 (HER2)
- Early breast cancer and metastatic breast cancer with HER2 positive tumours
- prevents production of VEGF
7
Q
Epidermal Growth Factor Receptor (eGFR)
A
- ‘Small molecule’ approach
- Certain Lung and pancreatic cancers
- Inhibits tyrosine kinase to target over proliferation of receptor
8
Q
Tyrosine kinase activity which chromosome can cause activity
A
- Philadelphia Chromosome associated with Chronic Myeloid Leukaemia
- Ph chromosome produces bcr-abl protein which has tyrosine kinase activity.
- Tyrosine kinase leads to uncontrolled cell proliferation
- Imatinib inhibits TK activity
- Selective inhibitor very effective for Chronic Myeloid Leukaemia
- Trials - >90% pts with CML alive after 5 years
- Gastro-intestinal stroma tumours
9
Q
Proteasome inhibitor
A
- Proteasomes: cellular structures which degrade proteins- including those that have pro-apoptotic factors
- Inhibition of intracellular proteasomes alters the regulation of intracellular proteins
10
Q
Anti-VEGF
A
also targeted